文献速递眼底病与葡萄膜炎

糖尿病脉络膜病变:扫频源光学相干断层扫描观察糖尿病视网膜病变中的脉络膜血管密度与体积

Diabetic Choroidopathy: Choroidal Vascular Density and Volume in Diabetic Retinopathy With Swept-Source Optical Coherence Tomography.
PubMed 文献 · Am J Ophthalmol · 2017-10-06

这项前瞻性多中心横断面研究纳入143只糖尿病眼(27只无糖尿病视网膜病变、47只非增殖性糖尿病视网膜病变、51只非增殖性糖尿病视网膜病变伴糖尿病黄斑水肿、18只增殖性糖尿病视网膜病变)和64只年龄匹配的非糖尿病对照眼,采用扫频源光学相干断层扫描测量脉络膜血管密度和体积。结果显示,与对照眼相比,非增殖性糖尿病视网膜病变伴糖尿病黄斑水肿眼的中心黄斑脉络膜血管密度显著降低9%,增殖性糖尿病视网膜病变眼降低15%,增殖性糖尿病视网膜病变眼的中心黄斑脉络膜血管体积显著降低19%。结论认为,在糖尿病视网膜病变的更晚期阶段,脉络膜血管密度和体积显著降低。

要点

  • 非增殖性糖尿病视网膜病变伴糖尿病黄斑水肿眼的中心黄斑脉络膜血管密度较对照眼显著降低9%。
  • 增殖性糖尿病视网膜病变眼的中心黄斑脉络膜血管密度较对照眼显著降低15%。
  • 增殖性糖尿病视网膜病变眼的中心黄斑脉络膜血管体积较对照眼显著降低19%。

核心结论

  • 在糖尿病视网膜病变的更晚期阶段,脉络膜血管密度和体积显著降低。

研究设计与样本

  • 前瞻性多中心横断面研究,纳入143只糖尿病眼和64只年龄匹配的非糖尿病对照眼。
  • 糖尿病眼包括27只无糖尿病视网膜病变、47只非增殖性糖尿病视网膜病变、51只非增殖性糖尿病视网膜病变伴糖尿病黄斑水肿和18只增殖性糖尿病视网膜病变。
  • 所有眼接受完整眼科检查和扫频源光学相干断层扫描成像,脉络膜血管的en face图像经二值化处理。
  • 采用多水平混合线性模型进行分析。

主要发现

  • 与对照眼(0.31 ± 0.07)相比,非增殖性糖尿病视网膜病变伴糖尿病黄斑水肿眼的中心黄斑脉络膜血管密度显著降低9%(0.28 ± 0.06;ß = -0.03,P = .02)。
  • 与对照眼(0.31 ± 0.07)相比,增殖性糖尿病视网膜病变眼的中心黄斑脉络膜血管密度显著降低15%(0.26 ± 0.05;ß = -0.04,P = .01)。
  • 与对照眼(0.025 ± 0.01 mm3)相比,增殖性糖尿病视网膜病变眼的中心黄斑脉络膜血管体积显著降低19%(0.020 ± 0.005 mm3;ß = -0.01,P = .01)。

关键数值与推荐

  • 中心黄斑脉络膜血管密度定义为以黄斑中心凹为中心、直径6 mm圆形区域内脉络膜血管所占面积百分比。
  • 后极部脉络膜血管密度评估范围为12 × 9 mm。
  • 中心黄斑脉络膜血管体积通过平均脉络膜血管密度乘以黄斑面积和脉络膜厚度计算,脉络膜厚度由扫频源光学相干断层扫描自动软件获取。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare choroidal vascular density (CVD) and volume (CVV) in diabetic eyes and controls, using en face swept-source optical coherence tomography (SS-OCT). DESIGN: Prospective cross-sectional study. METHODS: Setting: Multicenter. PATIENT POPULATION: Total of 143 diabetic eyes-27 with no diabetic retinopathy (DR), 47 with nonproliferative DR (NPDR), 51 with NPDR and diabetic macular edema (DME), and 18 with proliferative DR (PDR)-and 64 age-matched nondiabetic control eyes. OBSERVATION PROCEDURES: Complete ophthalmologic examination and SS-OCT imaging. En face SS-OCT images of the choroidal vasculature were binarized. MAIN OUTCOME MEASURES: CVD, calculated as the percent area occupied by choroidal vessels in the central macular region (6-mm-diameter circle centered on the fovea), and throughout the posterior pole (12 × 9 mm). The central macular CVV was calculated by multiplying the average CVD by macular area and choroidal thickness (obtained with SS-OCT automated software). Multilevel mixed linear models were performed for analyses. RESULTS: Compared to controls (0.31 ± 0.07), central macular CVD was significantly decreased by 9% in eyes with NPDR + DME (0.28 ± 0.06; ß = -0.03, P = .02) and by 15% in PDR (0.26 ± 0.05; ß = -0.04, P = .01). The central macular CVV was significantly decreased by 19% in eyes with PDR (0.020 ± 0.005 mm3, ß = -0.01, P = .01) compared to controls (0.025 ± 0.01 mm3). CONCLUSIONS: Choroidal vascular density and volume are significantly reduced in more advanced stages of diabetic retinopathy. New imaging modalities should allow further exploration of the contributions of choroidal vessel disease to diabetic eye disease pathogenesis, prognosis, and treatment response.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Wang JC, Laíns I, Providência J, et al. Diabetic Choroidopathy: Choroidal Vascular Density and Volume in Diabetic Retinopathy With Swept-Source Optical Coherence Tomography. Am J Ophthalmol. 2017. PMID: 28988899. doi:10.1016/j.ajo.2017.09.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。